Related posts
Nervous markets await NvidiaThis summary was created by AI, based on 1 opinions in the last 12 months.
Genpact Ltd (G-N) has received positive reviews from analysts, with experts praising the company's steady and reliable business model in the outsourcing sector. Noteworthy is its growing cash reserves, active debt reduction, and share buyback strategy, pointing to a healthy financial position. The stock currently trades at 17 times earnings and has a price-to-book ratio of 3.6, which reflects a strong return on equity at 22%. Analysts highlight a potential upside of over 18%, recommending a stop-loss at $35 in order to aim for a target price of $59. Although the yield is modest at 0.7%, the overall outlook remains optimistic with an average price target of $58.56 set by experts.
Genpact Ltd is a American stock, trading under the symbol G-N on the New York Stock Exchange (G). It is usually referred to as NYSE:G or G-N
In the last year, there was no coverage of Genpact Ltd published on Stockchase.
Genpact Ltd was recommended as a Top Pick by on . Read the latest stock experts ratings for Genpact Ltd.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
In the last year 0 stock analysts on Stockchase covered Genpact Ltd. The stock is worth watching.
On 2025-05-08, Genpact Ltd (G-N) stock closed at a price of $42.04.
G is a top rated supplier of business outsourcing services worldwide — a steady and reliable business. We like that cash reserves are growing, while debt is retired and shares bought back. It trades at 17x earnings, 3.6x book and supports a respectable ROE of 22%. We recommend setting a stop-loss at $35, looking to achieve $59 — upside potential over 18%. Yield 0.7%
(Analysts’ price target is $58.56)